Cancer vaccine therapy using peptides derived from tumor-rejection antigens

Japanese Journal of Cancer and Chemotherapy

Volumn 24, Issue 5, 1997, Pages 511-519

  Akiyoshi, T ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Antigenic peptide; Cancer vaccine; Cytotoxic T lymphocyte; Tumor rejection antigen

Indexed keywords

CANCER VACCINE; HLA ANTIGEN CLASS 1; PEPTIDE; TUMOR ANTIGEN;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN SPECIFICITY; CYTOTOXIC T LYMPHOCYTE; GENETIC CODE; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNIZATION; MELANOMA; REVIEW; TUMOR REJECTION;

ANTIGENS, NEOPLASM; ESOPHAGEAL NEOPLASMS; HLA ANTIGENS; HUMANS; IMMUNOTHERAPY, ACTIVE; MELANOMA; PEPTIDES; STOMACH NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0030884193     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)